AMBITION Protocol Reduces Toxicity Without Compromising Outcomes in HIV-Associated Cryptococcal Meningitis: JAMA
A new study published in the Journal of American Medical Association showed no differences in mortality or recurrence between the AMBITION treatment and a daily amphotericin-based regimen in HIV-associated cryptococcal…